Constellation Brands Inc. (NYSE:STZ) received a $181.00 price target from equities researchers at RBC Capital Markets in a note issued to investors on Wednesday. The brokerage presently has a a “buy” rating on the stock. RBC Capital Markets’ price objective points to a potential upside of 9.06% from the stock’s previous close.
A number of other brokerages have also recently commented on STZ. Zacks Investment Research raised Constellation Brands from a “hold” rating to a “buy” rating and set a $186.00 price target on the stock in a research report on Friday, September 16th. Susquehanna reaffirmed a “hold” rating and set a $155.00 price target on shares of Constellation Brands in a research report on Tuesday, June 28th. Wells Fargo & Co. reaffirmed a “buy” rating on shares of Constellation Brands in a research report on Thursday, June 30th. Morgan Stanley reaffirmed a “buy” rating on shares of Constellation Brands in a research report on Thursday, September 15th. Finally, Credit Agricole SA reaffirmed an “outperform” rating on shares of Constellation Brands in a research report on Monday, August 22nd. Six investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $174.79.
Shares of Constellation Brands (NYSE:STZ) traded down 0.45% on Wednesday, hitting $165.21. The company had a trading volume of 786,603 shares. The firm has a market capitalization of $33.13 billion, a price-to-earnings ratio of 29.76 and a beta of 0.72. Constellation Brands has a 1-year low of $123.51 and a 1-year high of $168.68. The company has a 50 day moving average price of $165.23 and a 200 day moving average price of $159.41.
Constellation Brands (NYSE:STZ) last posted its quarterly earnings data on Thursday, June 30th. The company reported $1.54 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.52 by $0.02. Constellation Brands had a return on equity of 17.66% and a net margin of 15.53%. The business had revenue of $1.87 billion for the quarter. During the same period in the prior year, the firm posted $1.26 EPS. The firm’s revenue for the quarter was up 14.8% on a year-over-year basis. On average, equities analysts forecast that Constellation Brands will post $6.31 earnings per share for the current fiscal year.
In related news, VP Thomas J. Mullin sold 30,000 shares of the stock in a transaction dated Wednesday, July 6th. The stock was sold at an average price of $165.73, for a total transaction of $4,971,900.00. Following the completion of the sale, the vice president now directly owns 101,702 shares in the company, valued at approximately $16,855,072.46. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO David Eric Klein sold 14,300 shares of the stock in a transaction dated Tuesday, July 5th. The shares were sold at an average price of $166.27, for a total value of $2,377,661.00. Following the sale, the chief financial officer now owns 36,152 shares of the company’s stock, valued at $6,010,993.04. The disclosure for this sale can be found here. Insiders own 10.63% of the company’s stock.
Large investors have recently modified their holdings of the stock. NN Investment Partners Holdings N.V. bought a new stake in shares of Constellation Brands during the first quarter valued at $165,000. Columbia Partners L L C Investment Management boosted its stake in Constellation Brands by 0.4% in the first quarter. Columbia Partners L L C Investment Management now owns 65,585 shares of the company’s stock valued at $9,909,000 after buying an additional 257 shares during the period. Howard Hughes Medical Institute boosted its stake in Constellation Brands by 4.7% in the first quarter. Howard Hughes Medical Institute now owns 47,566 shares of the company’s stock valued at $7,187,000 after buying an additional 2,143 shares during the period. BlackRock Group LTD boosted its stake in Constellation Brands by 2.7% in the first quarter. BlackRock Group LTD now owns 1,342,421 shares of the company’s stock valued at $202,825,000 after buying an additional 35,355 shares during the period. Finally, BlackRock Inc. boosted its stake in Constellation Brands by 5.2% in the first quarter. BlackRock Inc. now owns 306,667 shares of the company’s stock valued at $46,334,000 after buying an additional 15,043 shares during the period. Institutional investors own 75.05% of the company’s stock.
Constellation Brands Company Profile
Constellation Brands, Inc is an international beverage alcohol company. The Company is a producer and marketer of beer and wine the United States and Canada. Its segments include Beer, Wine and Spirits, and Corporate Operations and Other. It is a multi-category supplier (beer, wine and spirits) of beverage alcohol in the United States.
Receive News & Ratings for Constellation Brands Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellation Brands Inc. and related companies with MarketBeat.com's FREE daily email newsletter.